New horizontal flow wrapping machine for hermetic packages
Greater product protection thanks to reliable sealing technologies.
Hermetic packages protect pharmaceutical products from external influences such as humidity, oxygen and light. The new horizontal flow wrapping machine Sigpack HML from Bosch Packaging Technology, allows products such as blow-fill-seal vial cards, blisters and various medical technology products including pens and inhalers to be reliably hermetically packaged.
“Thanks to its compact size, the Sigpack HML can be optimally employed even where space is limited,” explains Rolf Steinemann, product manager at Bosch Packaging Technology. “The machine not only can seamlessly be integrated into their lines, it is also suited as an excellent stand-alone solution. This means customers benefit from even greater flexibility in the packaging process.”
Automatic splicing
The Sigpack HML is suitable for the production of both small and large batches. Depending on the desired output volume, the film reels can either be changed manually during short machine stops or with the help of a splicer. The improved splicer fully automatic connects the old and new film to avoid disturbances, such as at the film former.
Safe product processing
Products are delivered to the flow wrapping machine via a transport chain. The transverse and longitudinal film sealing uses the proven Longdwell heat sealing technology. “This ensures an extra-long sealing time, resulting in guaranteed tightly sealed seams, which means optimal protection for pharmaceutical products,” Steinemann says. The machine achieves an output of up to 350 sealed packages per minute.
The sealing rolls used for horizontal wrapping can be opened from both sides. This prevents the film from coming into contact with the heated sealing rolls, and from being damaged during machine downtime. For particularly temperature-sensitive products, the cover plates at the sealing station can be cooled. The Sigpack HML is also available with ultrasonic sealing, allowing customers to gently package heat-sensitive products.
Options for highest product quality
Upon request, the Sigpack HML can be equipped with options for additional product protection, such as the “no gap no seal” function. This is especially used for product piles in blister or BFS packages, which is checked once again shortly before it reaches the cross sealing. If the pile is not in the correct position, the cross sealing stops. This avoids product rejection or damaged sealing jaws. The optional MAP module (Modified Atmosphere Packaging) offers optimal product stability by removing residual oxygen from the hermetic packages. Sensors precisely monitor and regulate the gas content of the packages.
Consistent systems competence
Based on the Bosch systems competence, the Sigpack HML can be combined with other equipment, such as cartoning machines as well as track and trace systems for seamless traceability of the packaged products.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance